By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


AstraZeneca LP 

725 Chesterbrook Blvd.

Wayne  Pennsylvania  19087  U.S.A.
Phone: 610-695-1000 Fax: 610-889-1280




Company News
AstraZeneca LP (AZN) Raided By European Antitrust Officials 12/3/2010 9:36:53 AM
FDA Panel Backs AstraZeneca LP (AZN)'s Drug, Vandetanib, For Rare Thyroid Cancer but Asked to Rethink Drug Dosage 12/3/2010 7:03:37 AM
Prometheus Laboratories Inc. Extends Distribution Agreement for ENTOCORT(R) EC (budesonide) Capsules with AstraZeneca LP (AZN) 12/1/2010 7:21:45 AM
AstraZeneca LP (AZN) Loses Canada Court Case Over Generic Nexium 6/17/2010 6:57:16 AM
AstraZeneca LP (AZN) Secures Approval For Two New Dosage Strengths Of Atacand Plus 2/9/2009 3:59:22 PM
Xenome Ltd Grants MedImmune License to xdiscover(TM) Venom Peptide Library 1/8/2009 11:39:32 AM
AstraZeneca LP (AZN) Awards Infosys Technologies Multi-Year, Multi-Million Dollar Global Services Deal 12/15/2008 8:43:29 AM
AstraZeneca LP (AZN) Drug For Seizures Fatal In Some Patients, Mayo Clinic Study 10/29/2008 7:03:21 AM
National Comprehensive Cancer Network, Abraxis BioScience, Inc. And AstraZeneca LP (AZN) Announce Collaboration To Conduct Anti-Cancer Drug Studies 10/7/2008 8:53:20 AM
AstraZeneca LP (AZN) Discontinues LEXXEL (enalapril maleate-felodipine ER) Tablets 12/28/2007 9:01:27 AM